Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avantika Gupta

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Cancer Discovery|November 10, 2025
Trastuzumab Deruxtecan (T-DXd) Resistance via Loss of HER2 Expression and BindingWanyi Chen, Avantika Gupta, Nicholas Mai, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
APOBEC3 mutagenesis drives therapy resistance in breast cancerAvantika Gupta, Andrea Gazzo, Pier Selenica, et al.
Nature Genetics|May 16, 2025
APOBEC3 mutagenesis drives therapy resistance in breast cancerAvantika Gupta, Andrea Gazzo, Pier Selenica, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2024
Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancerSi-Yang Liu, Tatiana Erazo, Justin Jee, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Cancer Discovery|November 10, 2025
Trastuzumab Deruxtecan (T-DXd) Resistance via Loss of HER2 Expression and BindingWanyi Chen, Avantika Gupta, Nicholas Mai, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
APOBEC3 mutagenesis drives therapy resistance in breast cancerAvantika Gupta, Andrea Gazzo, Pier Selenica, et al.
Nature Genetics|May 16, 2025
APOBEC3 mutagenesis drives therapy resistance in breast cancerAvantika Gupta, Andrea Gazzo, Pier Selenica, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2024
Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancerSi-Yang Liu, Tatiana Erazo, Justin Jee, et al.
Pageof 6